BSE filing, NSE: SBILIFE. Summary written from the filing by ALFA Finder's alert engine.
SBI Life Insurance Company Ltd: key numbers
- Share price
- ₹1,641.40
- Market cap
- ₹1,64,700 Cr
- Revenue (annual)
- ₹1,12,315 Cr
- Net profit (annual)
- ₹2,470 Cr
- P/E (TTM)
- 62.0×Sector 19.7×
- Promoter holding
- 55.31%-0.01% QoQ
- FII holding
- 20.68%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from SBI Life Insurance Company Ltd
All →SBI Life Insurance Company Earnings Call Transcript: Key Takeaways
SBI Life delivered a strong 19% growth in Value of New Business (VNB) and margin expansion, effectively managing a one-time ₹530 Cr GST impact while maintaining market leadership.
- Call
- Guides 14% growth
SBI Life Insurance Company Results Update
SBI Life's H1 FY27 profit after tax rose 17% to ₹12.7 billion. Gross written premium grew 13% and the solvency ratio is 1.97.
SBI Life Insurance Company Q2 FY27 Results: Net Profit ₹549.2 Cr, Up 11.0% YoY
SBI Life Insurance Company Ltd reported revenue from operations of ₹26,878 Cr (+8.2% YoY) and net profit of ₹549.2 Cr (+11.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹549.2 Cr · +11.0% YoY
SBI Life Insurance Company Board Meeting Date
SBI Life scheduled a board meeting on October 27, 2026, to consider and approve financial results for the quarter and half year ended September 30, 2026.
SBI Life Insurance Company Employee Stock Options
SBI Life Insurance has allotted 4,160 equity shares following the exercise of vested employee stock options under its 2018 scheme.
SBI Life Insurance Company Legal & Regulatory
SBI Life Insurance received a tax demand order of ₹1.13 Crore from the Rajasthan GST authority. The company intends to appeal against this order.
- Value
- ₹1.13 Cr
Other other announcement announcements
All →Setubandhan Infrastructure Other Announcement
RP informs exchanges that Setubandhan Infrastructure cannot file quarterly compliance documents due to depository fee non-payment. The company remains under CIRP with a pending NCLAT appeal.
Man Infraconstruction Other Announcement
Man Infraconstruction filed a Reg 32 quarterly statement confirming no deviation in use of preferential-warrant proceeds. No deviation or variation arose for the quarter ended September 30, 2026.
Black Buck Other Announcement
BlackBuck's ICRA monitoring agency report for Q1 FY27 confirms IPO proceeds utilization remains in line with stated objects. No deviation was observed in the quarter.
Raama Finance Other Announcement
Raama Finance appointed M/s. Kumar Gaurav & Co. as statutory auditor for three months effective October 29, 2026. The routine appointment carries no financial impact.
Teja Engineering Industries Other Announcement
Teja Engineering Industries filed a non-applicability certificate for Reg 27(2) Corporate Governance for Q1 FY27. As an NSE Emerge-listed SME, the company is exempt from this periodic disclosure.
Prism Medico and Pharmacy Other Announcement
Prism Medico and Pharmacy intimated BSE and MSEI that its corporate website is updated and functional per Regulation 46. This is a routine compliance undertaking with no financial impact.